Warning: file_put_contents(/opt/frankenphp/design.onmedianet.com/storage/proxy/cache/72b2dd95b9cbf53d364bf436fefe45a4.html): Failed to open stream: No space left on device in /opt/frankenphp/design.onmedianet.com/app/src/Arsae/CacheManager.php on line 36

Warning: http_response_code(): Cannot set response code - headers already sent (output started at /opt/frankenphp/design.onmedianet.com/app/src/Arsae/CacheManager.php:36) in /opt/frankenphp/design.onmedianet.com/app/src/Models/Response.php on line 17

Warning: Cannot modify header information - headers already sent by (output started at /opt/frankenphp/design.onmedianet.com/app/src/Arsae/CacheManager.php:36) in /opt/frankenphp/design.onmedianet.com/app/src/Models/Response.php on line 20
Indolizinylethylamine - Wikipedia Jump to content

Indolizinylethylamine

From Wikipedia, the free encyclopedia

Indolizinylethylamines are a group of indolizine derivatives closely related to the tryptamines (indolylethylamines). They include 2ZEDMA, 1ZP2MA, and 1Z2MAP1O. Indolizinylethylamines are known to act as non-hallucinogenic serotonin receptor agonists and as monoamine releasing agents.[1][2]

See also

[edit]

References

[edit]
  1. ^ WO patent 2023183613A2, Matthew J. Baggott, "Indolizine compounds for the treatment of mental disorders or inflammation", published 2023 September 28, assigned to Tactogen 
  2. ^ WO application 2023081306A1, Baggott MJ, "Indolizine compounds for the treatment of mental disorders or mental enhancement", published 11 May 2023, assigned to Tactogen